Jesse Kaye, PhD, is an Assistant Scientist at the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI).
Dr. Kaye’s research on tobacco and other substance use disorders focuses on understanding mechanisms that maintain addiction and using this knowledge to develop treatments that are more effective. He examines psychological and neurobiological processes related to risk, etiology, and treatment common across addictive disorders (e.g., stress neuroadaptations, stress-related relapse, cue-reactivity, withdrawal) as well as in special high-risk populations (e.g., Veterans, smokers with psychiatric comorbidities, co-occurring tobacco use and chronic pain). His research is translational in nature, aiming to bridge preclinical and clinical research in order to inform treatment development. Dr. Kaye’s research uses a diverse methodological toolbox spanning human laboratory psychophysiology and psychopharmacology methods through mobile health ecological momentary assessment (EMA) and randomized clinical trials.
Dr. Kaye obtained his PhD in Clinical Psychology at the University of Wisconsin – Madison. He completed his pre-doctoral Clinical Psychology internship and postdoctoral fellowship in addiction treatment and research at the William S. Middleton Memorial Veterans Hospital (Madison VA). He was awarded two individual predoctoral training grants from the Graduate Research Fellowship Program at the National Science Foundation (NSF) and the Ruth L. Kirschtein Predoctoral Individual National Research Service Award (NRSA, F31) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). He was awarded a Developmental Research Grant from UW-CTRI Transdisciplinary Tobacco Use Research Center (NCI). Dr. Kaye is a licensed Clinical Psychologist.
- Kaye JT, Johnson AL, Piper ME, Baker TB, & Cook JW (2020). Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Sessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy. Journal of Studies on Alcohol and Drugs, 81, 426-435. doi: 10.15288/jsad.2020.81.426. PMID: 32800078. PMCID: PMC7437557.
- Fronk GE, Sant’Ana SJ, Kaye JT, & Curtin JJ (2020). Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research. Annual Review of Clinical Psychology, 16, 401-430. doi: 10.1146/annurev-clinpsy-102419-125016; PMID: 32040338. PMCID: PMC7259491.
- Kaye JT, Bradford DE, Magruder KP, & Curtin JJ (2017). Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence. Journal of Studies on Alcohol and Drugs, 78, 353-371. doi: 10.15288/jsad.2017.78.353; PMID: 28499100. PMCID: PMC5440361.